"B-Lymphocyte Subsets" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				A classification of B-lymphocytes based on structurally or functionally different populations of cells.
    
			
			
				
				
					
						| Descriptor ID | 
										
							D016175
						 | 			
					
					
						| MeSH Number(s) | 
						
							 A11.063.438.450 A11.118.637.555.567.550.450 A11.118.637.555.567.562.200 A15.145.229.637.555.567.550.450 A15.145.229.637.555.567.562.200 A15.382.032.438.450 A15.382.490.555.567.550.300 A15.382.490.555.567.562.450 
						 | 
					
					
						| Concept/Terms | 
						
							B-Lymphocyte Subsets- B-Lymphocyte Subsets
 - B Lymphocyte Subsets
 - B-Lymphocyte Subset
 - Subset, B-Lymphocyte
 - Subsets, B-Lymphocyte
 - B-Cell Subsets
 - B Cell Subsets
 - B-Cell Subset
 - Subset, B-Cell
 - Subsets, B-Cell
 
  Effector B Cells- Effector B Cells
 - B Cell, Effector
 - B Cells, Effector
 - Cell, Effector B
 - Cells, Effector B
 - Effector B Cell
 - B-Lymphocytes, Effector
 - B Lymphocytes, Effector
 - B-Lymphocyte, Effector
 - Effector B-Lymphocyte
 - Effector B-Lymphocytes
 
  Be2 Cells- Be2 Cells
 - Be2 Cell
 - Cell, Be2
 - Cells, Be2
 - B2 Lymphocytes
 - B2 Lymphocyte
 - Lymphocyte, B2
 - Lymphocytes, B2
 - B-2 Lymphocytes
 - B 2 Lymphocytes
 - B-2 Lymphocyte
 - Lymphocyte, B-2
 - Lymphocytes, B-2
 - B Effector 2 Cells
 
  Be1 Cells- Be1 Cells
 - Be1 Cell
 - Cell, Be1
 - Cells, Be1
 - B-1 Lymphocytes
 - B 1 Lymphocytes
 - B-1 Lymphocyte
 - Lymphocyte, B-1
 - Lymphocytes, B-1
 - B-1 Cells
 - B 1 Cells
 - B-1 Cell
 - Cell, B-1
 - Cells, B-1
 - B Effector 1 Cells
 - B1 Lymphocytes
 - B1 Lymphocyte
 - Lymphocyte, B1
 - Lymphocytes, B1
 
  
						 | 
					
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "B-Lymphocyte Subsets".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "B-Lymphocyte Subsets".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "B-Lymphocyte Subsets" by people in this website by year, and whether "B-Lymphocyte Subsets" was a major or minor topic of these publications. 
				
					
                    To see the data from this visualization as text, 
click here. 
				 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2001 | 1 | 0 | 1 | 
| 2004 | 1 | 1 | 2 | 
| 2005 | 0 | 1 | 1 | 
| 2007 | 1 | 0 | 1 | 
| 2008 | 3 | 0 | 3 | 
| 2009 | 1 | 0 | 1 | 
| 2013 | 1 | 0 | 1 | 
| 2014 | 0 | 1 | 1 | 
| 2015 | 4 | 0 | 4 | 
| 2016 | 1 | 1 | 2 | 
| 2019 | 1 | 0 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "B-Lymphocyte Subsets" by people in Profiles.
						
					
								- 
								
Insights From Analysis of Human Antigen-Specific Memory B Cell Repertoires. Front Immunol. 2018; 9:3064.
															
								 
							
								- 
								
Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity. Arthritis Rheumatol. 2016 10; 68(10):2492-502.
															
								 
							
								- 
								
Human effector B lymphocytes express ARID3a and secrete interferon alpha. J Autoimmun. 2016 Dec; 75:130-140.
															
								 
							
								- 
								
Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials. Arthritis Res Ther. 2015 Aug 20; 17:215.
															
								 
							
								- 
								
Concordance of increased B1 cell subset and lupus phenotypes in mice and humans is dependent on BLK expression levels. J Immunol. 2015 Jun 15; 194(12):5692-702.
															
								 
							
								- 
								
B-lymphocyte-mediated delayed cognitive impairment following stroke. J Neurosci. 2015 Feb 04; 35(5):2133-45.
															
								 
							
								- 
								
IFN-ß treatment requires B cells for efficacy in neuroautoimmunity. J Immunol. 2015 Mar 01; 194(5):2110-6.
															
								 
							
								- 
								
Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA. Ann Rheum Dis. 2016 Jan; 75(1):242-52.
															
								 
							
								- 
								
Integrin CD11b negatively regulates BCR signalling to maintain autoreactive B cell tolerance. Nat Commun. 2013; 4:2813.
															
								 
							
								- 
								
In vivo sensitized and in vitro activated B cells mediate tumor regression in cancer adoptive immunotherapy. J Immunol. 2009 Sep 01; 183(5):3195-203.